Potent bicyclic lactam inhibitors of thrombin:: Part I:: P3 modifications

被引：22

作者：

St-Denis, Y

Augelli-Szafran, CE

Bachand, B

Berryman, KA

DiMaio, J

Doherty, AM

Edmunds, JJ

Leblond, L

Lévesque, S

Narasimhan, LS

Penvose-Yi, JR

Rubin, JR

Tarazi, M

Winocour, PD

Siddiqui, MA

机构：

[1] BioChem Therapeut Inc, Laval, PQ H7V 4A7, Canada

[2] Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 22期

关键词：

D O I：

10.1016/S0960-894X(98)00550-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Peptidomimetic inhibitors of general structure 1 have been prepared. Optimization of the binding affinities of these compounds through variation of the P3 hydrophobic residue is described. Selected substituted bicylic lactams displayed interesting pharmacological profiles both in vitro and in vivo. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：3193 / 3198

页数：6

共 10 条

[1] BACHAND B, 1998, UNPUB BIOORG MED CHE
[2] BERRYMAN KA, 1997, Patent No. 48687
[3] STEREOSELECTIVE ADDITION OF GRIGNARD-DERIVED ORGANOCOPPER REAGENTS TO N-ACYLIMINIUM IONS - SYNTHESIS OF ENANTIOPURE 5-SUBSTITUTED AND 4,5-SUBSTITUTED PROLINATES
COLLADO, I
EZQUERRA, J
PEDREGAL, C
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (16) : 5011 - 5015
[4] DIMAIO J, 1996, Patent No. 19483
[5] Thrombin and factor Xa inhibition
Edmunds, JJ
Rapundalo, ST
Siddiqui, MA
[J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 : 51 - 60
[6] THROMBIN STRUCTURE AND FUNCTION - WHY THROMBIN IS THE PRIMARY TARGET FOR ANTITHROMBOTICS
FENTON, JW
OFOSU, FA
MOON, DG
MARAGANORE, JM
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (01) : 69 - 75
[7] BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis - Comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban
Finkle, CD
St Pierre, A
Leblond, L
Deschenes, I
DiMaio, J
Winocour, PD
[J]. THROMBOSIS AND HAEMOSTASIS, 1998, 79 (02) : 431 - 438
[8] New routes to conformationally restricted peptide building blocks: A convenient preparation of bicyclic piperazinone derivatives
Fobian, YM
dAvignon, DA
Moeller, KD
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (03) : 315 - 318
[9] HARMON JT, 1986, J BIOL CHEM, V261, P5928
[10] Maraganore John M., 1994, Perspectives in Drug Discovery and Design, V1, P461, DOI 10.1007/BF02171860

← 1 →